United States · FDA National Drug Code directory
Fexofenadine HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11673-767_46534182-fd58-f797-e063-6294a90a5106
- Product NDC
- 11673-767
- Form
- TABLET
- Composition / generic term
- Fexofenadine HCL
- Labeler
- TARGET CORPORATION
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240301
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (11673-767-03) · 11673-767-03
- 15 TABLET in 1 BLISTER PACK (11673-767-07) · 11673-767-07
- 150 TABLET in 1 BOTTLE (11673-767-15) · 11673-767-15
- 70 TABLET in 1 BOTTLE (11673-767-34) · 11673-767-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →